Bionoid Pharma Pink Sheet Forecast - Triple Exponential Smoothing

Bionoid Pharma Additional Predictive Modules

Most predictive techniques to examine Bionoid price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Bionoid using various technical indicators. When you analyze Bionoid charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur. Triple exponential smoothing for Bionoid Pharma - also known as the Winters method - is a refinement of the popular double exponential smoothing model with the addition of periodicity (seasonality) component. Simple exponential smoothing technique works best with data where there are no trend or seasonality components to the data. When Bionoid Pharma prices exhibit either an increasing or decreasing trend over time, simple exponential smoothing forecasts tend to lag behind observations. Double exponential smoothing is designed to address this type of data series by taking into account any trend in Bionoid Pharma price movement. However, neither of these exponential smoothing models address any seasonality of Bionoid Pharma.

Bionoid Pharma Triple Exponential Smoothing Price Forecast For the 29th of January

Given 90 days horizon, the Triple Exponential Smoothing forecasted value of Bionoid Pharma on the next trading day is expected to be 0.03 with a mean absolute deviation of 0, mean absolute percentage error of 0.000031, and the sum of the absolute errors of 0.20.

Bionoid Pharma Pink Sheet Forecast Pattern

Backtest Bionoid Pharma

Bionoid Pharma Price Prediction

Buy or Sell Advice

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Triple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Bionoid Pharma pink sheet data series using in forecasting. Note that when a statistical model is used to represent Bionoid Pharma pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality. As with simple exponential smoothing, in triple exponential smoothing models past Bionoid Pharma observations are given exponentially smaller weights as the observations get older. In other words, recent observations are given relatively more weight in forecasting than the older Bionoid Pharma observations.

Predictive Modules for Bionoid Pharma

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bionoid Pharma. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 0.00 0.03 27.47 Details

Intrinsic Valuation Low Real High 0.00 0.03 27.47 Details

Bollinger Band Projection (param) Low Middle High 0.02 0.03 0.04 Details

Bionoid Pharma After-Hype Price Density Analysis

Bionoid Pharma Estimiated After-Hype Price Volatility

Bionoid Pharma Pink Sheet Price Outlook Analysis

Notes

Bionoid Pharma Hype Timeline

Bionoid Pharma is currently traded for 0.03. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Bionoid is estimated to increase in value after the next headline, with the price projected to jump to 0.03 or above. The average volatility of media hype impact on the company the price is insignificant. The price gain on the next news is estimated to be 5.63%, whereas the daily expected return is currently at 2.63%. The volatility of related hype on Bionoid Pharma is about 0.0%, with the expected price after the next announcement by competition of 0.03. Bionoid Pharma currently holds about 127 in cash with (357.62 K) of positive cash flow from operations. Given the investment horizon of 90 days the next estimated press release will be in 5 to 10 days. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

Bionoid Pharma Related Hype Analysis

Bionoid Pharma Related Equities

Risk & Return

Correlation

Bionoid Pharma Market Strength Events

Bionoid Pharma Risk Indicators

Story Coverage note for Bionoid Pharma

Other Macroaxis Stories

Additional Tools for Bionoid Pink Sheet Analysis